EI
IDXX icon

Ethic Inc’s Idexx Laboratories IDXX Stock Holding History

Ethic Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Sell
10,542
-400
-4% -$224K 0.07% 280
2026
Q1 		$6.15M Sell
10,942
-957
-8% -$614K 0.1% 223
2025
Q4 		$8.05M Buy
11,899
+432
+4% +$294K 0.12% 163
2025
Q3 		$7.33M Buy
11,467
+1,799
+19% +$1.09M 0.12% 166
2025
Q2 		$5.14M Buy
9,668
+1,011
+12% +$483K 0.09% 230
2025
Q1 		$3.62M Buy
8,657
+2,432
+39% +$1.06M 0.07% 280
2024
Q4 		$2.57M Sell
6,225
-958
-13% -$420K 0.05% 360
2024
Q3 		$3.88M Sell
7,183
-163
-2% -$79.2K 0.1% 241
2024
Q2 		$3.58M Buy
7,346
+163
+2% +$81.8K 0.08% 259
2024
Q1 		$3.88M Buy
7,183
+987
+16% +$539K 0.1% 242
2023
Q4 		$3.44M Buy
6,196
+803
+15% +$377K 0.1% 235
2023
Q3 		$2.36M Buy
5,393
+156
+3% +$77.8K 0.08% 280
2023
Q2 		$2.63M Buy
5,237
+447
+9% +$214K 0.1% 245
2023
Q1 		$2.4M Buy
4,790
+1,232
+35% +$590K 0.1% 248
2022
Q4 		$1.45M Buy
3,558
+184
+5% +$71.4K 0.08% 300
2022
Q3 		$1.1M Buy
3,374
+552
+20% +$203K 0.07% 302
2022
Q2 		$990K Sell
2,822
-130
-4% -$53K 0.07% 323
2022
Q1 		$1.61M Sell
2,952
-117
-4% -$61.5K 0.11% 239
2021
Q4 		$2.02M Buy
3,069
+383
+14% +$240K 0.16% 160
2021
Q3 		$1.67M Buy
2,686
+88
+3% +$59.1K 0.17% 152
2021
Q2 		$1.64M Buy
2,598
+671
+35% +$371K 0.2% 125
2021
Q1 		$943K Buy
1,927
+835
+76% +$418K 0.17% 163
2020
Q4 		$546K Buy
1,092
+444
+69% +$199K 0.14% 188
2020
Q3 		$255K Buy
+648
New +$240K 0.1% 259

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Ethic Inc's IDXX Position: Q2 2026 in Review

Ethic Inc reduced its Idexx Laboratories (IDXX) stake by 3.7% in Q2 2026, selling an estimated $224K and leaving 10,542 shares worth $5.55M. The position accounts for 0.07% of the portfolio, ranked #280.

Ethic Inc first reported a position in IDXX in Q3 2020 and has held it in 24 quarters since. The position peaked at $8.05M in Q4 2025. 454 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ethic Inc held 10,542 shares of Idexx Laboratories worth $5.55M as of Q2 2026.
  • Ethic Inc sold 400 Idexx Laboratories shares in Q2 2026, an estimated $224K.
  • Idexx Laboratories made up 0.07% of Ethic Inc's portfolio in Q2 2026, its #280 holding.
  • Ethic Inc first reported a position in Idexx Laboratories in Q3 2020 and has held it in 24 quarters since.
  • Ethic Inc's Idexx Laboratories position peaked at $8.05M in Q4 2025.
  • 454 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.